Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement : Results and consensus of the Global Biomarker Standardization Consortium
INTRODUCTION: Blood-based biomarkers (BBMs) have revolutionized Alzheimer's disease diagnosis and monitoring. Their pre-analytical stability requires scrutiny. This study assessed pre-analytical effects to inform a standardized sample handling protocol. METHODS: Assessed pre-analytical variations included collection tube type, hemolysis, centrifugation settings, centrifugation/storage delays, tube
